Variability in Antibiotic Use at Children's Hospitals

BACKGROUND: Variation in medical practice has identified opportunities for quality improvement in patient care. The degree of variation in the use of antibiotics in children's hospitals is unknown. METHODS: We conducted a retrospective cohort study of 556 692 consecutive pediatric inpatient discharges from 40 freestanding children's hospitals between January 1, 2008, and December 31, 2008. We used the Pediatric Health Information System to acquire data on antibiotic use and clinical diagnoses. RESULTS: Overall, 60% of the children received at least 1 antibiotic agent during their hospitalization, including >90% of patients who had surgery, underwent central venous catheter placement, had prolonged ventilation, or remained in the hospital for >14 days. Even after adjustment for both hospital- and patient-level demographic and clinical characteristics, antibiotic use varied substantially across hospitals, including both the proportion of children exposed to antibiotics (38%–72%) and the number of days children received antibiotics (368–601 antibiotic-days per 1000 patient-days). In general, hospitals that used more antibiotics also used a higher proportion of broad-spectrum antibiotics. CONCLUSIONS: Children's hospitals vary substantially in their use of antibiotics to a degree unexplained by patient- or hospital-level factors typically associated with the need for antibiotic therapy, which reveals an opportunity to improve the use of these drugs.

[1]  J. Bartlett,et al.  The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[3]  Arjun Srinivasan,et al.  Emergency department visits for antibiotic-associated adverse events. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Sharifzadeh,et al.  Anti‐infectives‐induced adverse drug reactions in hospitalized patients , 2005, Pharmacoepidemiology and drug safety.

[5]  L. Grohskopf,et al.  Use of Antimicrobial Agents in United States Neonatal and Pediatric Intensive Care Patients , 2005, The Pediatric infectious disease journal.

[6]  Alexander Kopp,et al.  Outpatient gatifloxacin therapy and dysglycemia in older adults. , 2006, The New England journal of medicine.

[7]  F A Connell,et al.  Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. , 2000, Pediatrics.

[8]  J. Bartlett Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.

[9]  Conan MacDougall,et al.  Variability in Rates of Use of Antibacterials Among 130 US Hospitals and Risk-Adjustment Models for Interhospital Comparison , 2008, Infection Control & Hospital Epidemiology.

[10]  J. Bartlett,et al.  Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.

[11]  J F Steiner,et al.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.

[12]  R. Gaynes,et al.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  A. Pakyz,et al.  Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers , 2009, Infection Control & Hospital Epidemiology.

[14]  Ralph Gonzales,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[15]  Nnis System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[16]  A. Pakyz,et al.  Trends in antibacterial use in US academic health centers: 2002 to 2006. , 2008, Archives of internal medicine.

[17]  L. Rice The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Carlos G. Grijalva,et al.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.

[19]  R. Polk,et al.  Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Shuster Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care , 2011 .

[21]  S. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[23]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Spencer E. Harpe,et al.  Diversity of Antimicrobial Use and Resistance in 42 Hospitals in the United States , 2008, Pharmacotherapy.

[25]  Forum on Emerging Infections Antimicrobial Resistance: Issues and Options , 1998 .

[26]  A. MacGowan,et al.  Clinical implications of antimicrobial resistance for therapy. , 2008, The Journal of antimicrobial chemotherapy.

[27]  P. Polgreen,et al.  Antimicrobial Stewardship Programs in Pediatrics , 2009, Infection Control & Hospital Epidemiology.

[28]  K. Kelleher,et al.  Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. , 2002, Archives of pediatrics & adolescent medicine.

[29]  D. Gerding,et al.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.

[30]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[31]  R. Platt,et al.  Antimicrobial use in defined populations of infants and young children. , 2000, Archives of pediatrics & adolescent medicine.

[32]  J. Hughes,et al.  Trends in antimicrobial prescribing rates for children and adolescents. , 2002, JAMA.

[33]  A. Ranaweera,et al.  Antimicrobial resistance , 1999 .

[34]  D. Paterson "Collateral damage" from cephalosporin or quinolone antibiotic therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.